ASTH (NASDAQ: ASTH) reported Q1 EPS of $0.14, $0.16 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $620.4 million versus the consensus estimate of $628.11 million.

GUIDANCE:

ASTH sees Q2 2025 revenue of $615-655 million, versus the consensus of $660.7 million.

ASTH sees FY2025 revenue of $2.5-2.7 billion, versus the consensus of $2.64 billion.

For earnings history and earnings-related data on ASTH (ASTH) click here.